Light-based therapy weakens antibiotic-resistant bacteria

Light-based therapy weakens antibiotic-resistant bacteria
Schematic representation of single and combined antibiotic and aPDT treatment options for infections. Antibiotics serve an important role in medicine, successfully treating many common bacterial infections. However, their use leads to increased resistance, necessitating more dangerous antibiotic classes and higher doses. Likewise, aPDT can successfully eliminate bacteria, regardless of antibiotic resistance, but is not always applicable at large doses due to drug and light side effects. These two treatments used concurrently have been found to significantly lower average antibiotic resistance and broaden the resistance distribution, permitting the use of smaller doses of each for a more effective treatment. Credit: Proceedings of the National Academy of Sciences (2022). DOI: 10.1073/pnas.2208378119

Antibiotics are standard treatments for fighting dangerous bacterial infections. Yet the number of bacteria developing a resistance to antibiotics is increasing. Researchers from Texas A&M University and the University of São Paulo are overcoming this resistance with light.

The researchers tailored antimicrobial (aPDT)—a chemical reaction triggered by visible light—for use on strains. Results showed the treatment weakened to where low doses of current antibiotics could effectively eliminate them.

"Using aPDT in combination with antibiotics creates a synergy of interaction working together for a solution," said Vladislav Yakovlev, University Professor in the Department of Biomedical Engineering at Texas A&M and co-director of the project. "It's a step in the right direction against resistant bacteria."

The research results were published in Proceedings of the National Academy of Sciences (PNAS).

Ultraviolet light was first used to sterilize bacteria over 100 years ago. The treatment was based on the work of Niels Finsen, who won the Nobel Prize in Physiology in 1903 for using filtered sunlight—the higher frequency or ultraviolet spectrum—as a cure for skin tuberculosis. Phototherapy advances faded in popularity a few decades later when antibiotics became the weapon of choice against bacteria.

Antibiotic-resistant bacteria showed up soon after antibiotics were first used. If antibiotic treatment stops before bacteria are fully killed, the remaining bacteria develop a resistance or immunity to the antibiotic. That immunity transfers to every new bacteria cell, so more potent antibiotics or new treatment methods are needed to overcome the growing resistance.

"Photodynamic therapy was a forgotten tool," Yakovlev said. "Yet, bacteria cannot overcome it. There is no resistance."

Some human cancer cell therapies already use aPDT to prevent the growth of abnormal cells, but treating resistant bacteria with it is still a novel approach.

The researchers began their work by choosing the bacteria and the three main parts of aPDT needed to combat it: molecular oxygen, light, and a photosensitizer—something that creates a reaction between oxygen and light. An already FDA-approved dye called methylene blue served as the photosensitizer. The light sources were specially constructed panels of 25 LEDs in reflective cones built by the Technical Support Laboratory of the São Carlos Institute of Physics. Methicillin-resistant Staphylococcus aureus served as the bacteria, and the researchers grew cultures with the blue dye in them to ensure the photosensitizer alone would not affect the bacteria.

Most of the lab work occurred in the Texas A&M Health Science Center under Paul de Figueiredo, professor in the Department of Microbial Pathogenesis and Immunology in the College of Medicine.

At first, the team used aPDT by itself at various light strengths, durations, and in a specific series of follow-up treatments to log the bacteria's response. The idea was to find the lowest dose and shortest series that could weaken the bacterial membranes and other resistance mechanisms. Cell recoveries and reproductions revealed how many generations it took before antibiotic resistance returned. Next, the researchers added measured levels and combinations of antibiotics at different time intervals after aPDT treatments to note the weakened bacteria's responses.

"The use of antibiotics with aPDT is a unique idea," Yakovlev said. "We can use lower doses of both to achieve our goal in contrast to using one or the other at higher doses that could have side effects."

The goal is to shorten the treatment time and reduce the dosage to the lowest levels needed.

Getting down to one doctor visit is especially important to Vanderlei Bagnato, professor in the Department of Physics and Materials Science at São Paulo and co-director of the project. He is trying to improve recovery odds for populations in remote areas of Brazil where patients might only see a doctor once per illness, without any chance for follow-up care.

The U.S. Department of Defense is following the project closely because battlefield wound infections also happen in remote locations and must be dealt with quickly.

So far, the results are positive. The resistant bacteria, weakened by aPDT treatments, were killed with far lower doses of current antibiotics. As a benefit, these therapies reduced the need for battling resistant bacteria with more potent and expensive that take years to produce. Future work for the project will involve more timing and dosage investigations and tests on other strains to see if the effectiveness is universal.

"Imagine the real-life applications," Yakovlev said. "You visit a doctor, who uses an ointment and shines a light on the infected area, and then you're done. It would be a quick and harmless treatment as needed."

More information: Jace A. Willis et al, Breaking down antibiotic resistance in methicillin-resistant Staphylococcus aureus : Combining antimicrobial photodynamic and antibiotic treatments, Proceedings of the National Academy of Sciences (2022). DOI: 10.1073/pnas.2208378119

Citation: Light-based therapy weakens antibiotic-resistant bacteria (2022, October 7) retrieved 6 December 2022 from https://phys.org/news/2022-10-light-based-therapy-weakens-antibiotic-resistant-bacteria.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New drug candidate fights off more than 300 drug-resistant bacteria

150 shares

Feedback to editors